We remain committed to working closely with the FDA to ensure that physicians and patients are provided with accurate information about any potential risks associated with the use of our products." On October 30, the FDA approved an expanded indication for BYETTA as a stand-alone medication (monotherapy) along with diet and exercise to improve glycemic control in adults with type 2 diabetes
AMS Edmonton, Alberta Hogan AE, Tobin AM, Ahern T, Corrigan MA, Gaoatswe G, Jackson R, OReilly V, Lynch L, Doherty DG, Moynagh PN, Kirby B, OConnell J, & OShea D (2011)
Supplementation might benefit those with deficiency-related symptoms
Here's what we'll cover Key takeaways Without insurance, Zepbound can cost $299$1,086.37 for a one-month supply, but insurance and discount cards can help lower the cost
doi: 10.1016/j.neurobiolaging.2012.04.009 53 KellyPMcCleanPLAckermannMKonerdingMAHlscherCMitchellCA
adults reported that they had previously used a GLP-1 medication (Montero, et al., 2024), which has been increasing in popularity (e.g., Regalado, 2024